Wall Street Journalのインスタグラム(wsj) - 1月8日 00時18分

Contract-manufacturing companies working to accelerate the global availability of Covid-19 vaccines are struggling with a shortage of their own: There aren’t enough workers to meet this year’s big production push.⁠⠀
⁠⠀
More than 5,000 open jobs exist at the world’s 10 largest companies that have won Covid-19 outsourcing work, according to a Wall Street Journal analysis of the companies’ websites. The labor crunch is another potential drag on a global vaccine rollout already facing a supply backlog and requiring near-flawless logistics.⁠⠀
⁠⠀
World production of Covid-19 vaccines is expected to reach 6 billion doses in 2021, according to industry tracker PharmSource. Nearly every major pharmaceutical company with a potential vaccine candidate has enlisted the contract manufacturers to help meet production targets. ⁠⠀
⁠⠀
Many contract manufacturers are trying to fill roles that often require years of experience in pharmaceutical manufacturing or biotechnology-related degrees. They are also struggling to hire staff willing to work overnight shifts, as production goes round-the-clock. The jobs are likely to be permanent.⁠⠀
⁠⠀
Read more at the link in our bio.⁠⠀
⁠⠀
Photo: Vincenzo Pinto/AFP/Getty Images

[BIHAKUEN]UVシールド(UVShield)

>> 飲む日焼け止め！「UVシールド」を購入する